Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
Leukemia & Lymphoma Society
NCCN Guidelines for Patients
NCCN COVID-19 Resources Page
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL